Cover Image
市場調查報告書

使用美國的泌尿系統相關設備的醫療治療數量

US Procedure Numbers for Urological Devices 2016 - MedPro

出版商 iData Research Inc. 商品編碼 362135
出版日期 內容資訊 英文 95 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
使用美國的泌尿系統相關設備的醫療治療數量 US Procedure Numbers for Urological Devices 2016 - MedPro
出版日期: 2016年07月01日 內容資訊: 英文 95 Pages
簡介

本報告提供美國的泌尿系統相關設備的各種醫療治療的數量調查,泌尿系統相關設備的市場概要,主要趨勢,競爭環境,疾病區分、各治療種類的治療數量等彙整資料。

第1章 摘要整理

  • 泌尿系統相關設備的美國市場
  • 競爭分析
  • 市場趨勢
  • 對象市場
  • 手術、治療數量
  • 對象手術、治療編碼
  • 市場發展等

第2章 調查手法

第3章 治療數量

  • 對象治療編碼
  • 治療概要
  • 尿失禁
    • 男性尿失禁管理
      • 吊帶治療
      • 吊帶消除治療
      • 人工尿道括約肌治療
    • 女性尿失禁管理
      • 經陰道膠帶式吊帶
      • 經閉孔式吊帶
      • 單孔式吊帶
      • 吊帶去除
      • 尿道懸吊系統
  • 結石管理
    • ESWL
    • 經尿道治療
      • 結石碎石術
      • 其他
    • 輸尿管支架留置
    • PCNL
  • 對BPH (前列腺肥大症) 的治療
    • BPH患者統計
    • 對BPH的治療
      • TURP
      • 雷射治療
      • 前列腺支架置入
      • TUMT
      • TUNA
      • Botox®注射
  • 前列腺癌治療
    • 前列腺癌統計
    • 前列腺癌的治療處理
      • 後續觀察
      • 前列腺摘除術
    • 前列腺切除
      • 凍結燒灼術
      • 微波燒灼術
      • 無線電趨勢燒灼術
    • 放射治療
      • 高線量率近接治療
      • 低劑量率近接治療
      • 體外放射治療
  • 尿流動態檢驗
    • 膀胱內壓檢測
    • 尿流檢測
  • 腎瘺造設
    • 腎瘺造設
    • 經皮腎瘺造設
  • 勃起功能障礙管理
    • 膨脹式ED設備插入
    • 展性ED設備插入
    • ED設備消除

用語

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: iDATA_USUR16_MP

The procedures covered in this report suite includes urinary incontinence, stone management, benign prostate hyperplasia (BPH), prostate cancer treatment, urodynamic testing, nephrostomy and erectile dysfunction management procedures. Each category is further segmented into more specific procedure types.

Segments Covered in this Procedure Volume Research

This market study focuses specifically on the volume of procedures. It includes analysis of procedures.

This data outlines the exact growth rates for procedures. If you're interested in seeing the trends in procedures to formulate your market sizing and forecasts this is the most accurate and most affordable way to do it.

About Procedure Volume Research (MedPro)

Our analysts meticulously research for 3 to 4 months to put together a suite of reports, which is a comprehensive analysis on a group of healthcare markets. A MedPro is one portion of that analysis that outlines only the procedure volumes and forecasts for each market in that suite of reports.

This procedural analysis is incorporated in our market size analysis and forecasting which are available when purchasing a MedSuite, MedView or MedCore.

Where Do We Get Our Procedure Data?

Our team of analysts has proprietary data that we've been collecting for over a decade as well as government and private databases like that from CMS and hospital records. By looking at multiple sources we are able to triangulate on orthopedic soft tissue procedure volumes that influence and coincide with our overall market sizing.

Questions This Report will Help You Answer:

What is affecting the volume of procedures?

How many procedures were done in 2016?

How many procedures were done historically?

How many procedures can we expect in 2023 and what is the growth trend?

TABLE OF CONTENTS I

LIST OF FIGURES V

LIST OF CHARTS VIII

EXECUTIVE SUMMARY 1

  • 1.1 U.S. UROLOGICAL DEVICE MARKET OVERVIEW 1
  • 1.2 COMPETITIVE ANALYSIS 3
  • 1.3 MARKET TRENDS 6
  • 1.4 MARKETS INCLUDED 8
  • 1.5 PROCEDURE NUMBERS 13
  • 1.6 PROCEDURE CODES INVESTIGATED 15
  • 1.7 MARKET DEVELOPMENTS 16
  • 1.8 KEY REPORT UPDATES 17
  • 1.9 VERSION HISTORY 17

RESEARCH METHODOLOGY 19

  • 2.1 RESEARCH SCOPE 19
  • 2.2 IDATA'S 9-STEP METHODOLOGY 19
    • Step 1: Project Initiation & Team Selection 19
    • Step 2: Prepare Data Systems and Perform Secondary Research 22
    • Step 3: Preparation for Interviews & Questionnaire Design 23
    • Step 4: Performing Primary Research 24
    • Step 5: Research Analysis: Establishing Baseline Estimates 26
    • Step 6: Market Forecast and Analysis 27
    • Step 7: Identify Strategic Opportunities 29
    • Step 8: Final Review and Market Release 30
    • Step 9: Customer Feedback and Market Monitoring 31

PROCEDURE NUMBERS 32

  • 3.1 PROCEDURE CODES INVESTIGATED 32
  • 3.2 PROCEDURE OVERVIEW 33
  • 3.3 URINARY INCONTINENCE PROCEDURES 36
    • 3.3.1 Male Incontinence Management Procedures 38
      • 3.3.1.1 Male Incontinence Sling Procedures 38
      • 3.3.1.2 Male Incontinence Sling Removal Procedures 38
      • 3.3.1.3 Male Artificial Urinary Sphincter Procedures 38
    • 3.3.2 Female Incontinence Management Procedures 40
      • 3.3.2.1 Transvaginal Tape Female Incontinence Sling Procedures 40
      • 3.3.2.2 Transobturator Female Incontinence Sling Procedures 40
      • 3.3.2.3 Single-Incision Female Incontinence Sling Procedures 40
      • 3.3.2.4 Female Incontinence Sling Removal Procedures 40
      • 3.3.2.5 Female Urethral Suspension Procedures 40
  • 3.4 STONE MANAGEMENT PROCEDURES 44
    • 3.4.1 ESWL Procedures 46
    • 3.4.2 Transurethral Procedures 47
      • 3.4.2.1 Lithotripsy Procedures 47
      • 3.4.2.2 Non-Lithotripsy Procedures 47
    • 3.4.3 Ureteral Stent Placement Procedures 49
    • 3.4.4 PCNL Procedures 50
  • 3.5 BPH PROCEDURES 51
    • 3.5.1 BPH Patient Statistics 51
    • 3.5.2 BPH Procedures 53
      • 3.5.2.1 TURP Procedures 55
      • 3.5.2.2 Laser BPH Procedures 56
      • 3.5.2.3 Prostatic Stent Placement Procedures 57
      • 3.5.2.4 TUMT Procedures 58
      • 3.5.2.5 TUNA Procedures 59
      • 3.5.2.6 Botox® Injection Procedures 60
  • 3.6 PROSTATE CANCER TREATMENT PROCEDURES 61
    • 3.6.1 Prostate Cancer Statistics 61
    • 3.6.2 Prostate Cancer Treatment Procedures 63
      • 3.6.2.1 Watchful Waiting 64
      • 3.6.2.2 Prostatectomy Procedures 65
      • 3.6.2.2.1 Open Prostatectomy Procedures 65
      • 3.6.2.2.2 Laparoscopic Prostatectomy Procedures 65
      • 3.6.2.2.3 Robotic Prostatectomy Procedures 65
    • 3.6.3 Prostate Ablation Procedures 70
      • 3.6.3.1 Cryotherapy Tumor Ablation Procedures 70
      • 3.6.3.2 Microwave Tumor Ablation Procedures 70
      • 3.6.3.3 RF Tumor Ablation Procedures 70
    • 3.6.4 Radiation Therapy Procedures 72
      • 3.6.4.1 Prostate HDR Brachytherapy Procedures 73
      • 3.6.4.2 Prostate LDR Brachytherapy Procedures 74
      • 3.6.4.2.1 Cs-131 Procedures 74
      • 3.6.4.2.2 Pd-103 Procedures 74
      • 3.6.4.2.3 I-125 Procedures 74
      • 3.6.4.3 External Radiation Therapy Procedures 76
      • 3.6.4.3.1 Linear Accelerator Procedures 76
      • 3.6.4.3.2 Proton Therapy Procedures 76
  • 3.7 URODYNAMIC TESTING PROCEDURES 78
    • 3.7.1 Cystometrogram Procedures 80
      • 3.7.1.1 Simple Cystometrogram Procedures 80
      • 3.7.1.2 Complex Cystometrogram Procedures 80
    • 3.7.2 Uroflowmetry Procedures 82
      • 3.7.2.1 Simple Uroflowmetry Procedures 82
      • 3.7.2.2 Complex Uroflowmetry Procedures 82
  • 3.8 NEPHROSTOMY PROCEDURES 84
    • 3.8.1 Nephrostomy/Nephrotomy Procedures 86
    • 3.8.2 Percutaneous Nephrostomy Procedures 87
  • 3.9 ERECTILE DYSFUNCTION MANAGEMENT PROCEDURES 88
    • 3.9.1 Insertion of Inflatable ED Device Procedures 91
    • 3.9.2 Insertion of Malleable ED Device Procedures 92
    • 3.9.3 Removal of ED Device Procedures 93

ABBREVIATIONS 94

LIST OF CHARTS

  • Chart 1 1: Urological Device Market by Segment, U.S., 2012 - 2022 2
  • Chart 1 2: Urological Device Market Overview, 2015 and 2022 2
  • Chart 3 1: Urological Procedures by Type, U.S., 2012 - 2022 35
  • Chart 3 2: Urinary Incontinence Procedures by Type, U.S., 2012 - 2022 37
  • Chart 3 3: Male Incontinence Management Procedures by Type, U.S., 2012 - 2022 39
  • Chart 3 4: Female Incontinence Management Procedures by Type, U.S., 2012 - 2022 43
  • Chart 3 5: Stone Management Procedures by Type, U.S., 2012 - 2022 45
  • Chart 3 6: ESWL Procedures, U.S., 2012 - 2022 46
  • Chart 3 7: Transurethral Procedures by Type, U.S., 2012 - 2022 48
  • Chart 3 8: Ureteral Stent Placement Procedures, U.S., 2012 - 2022 49
  • Chart 3 9: PCNL Procedures, U.S., 2012 - 2022 50
  • Chart 3 10: BPH Patient Statistics, U.S., 2012 - 2022 52
  • Chart 3 11: BPH Procedures by Type, U.S., 2012 - 2022 54
  • Chart 3 12: TURP Procedures, U.S., 2012 - 2022 55
  • Chart 3 13: Laser BPH Procedures, U.S., 2012 - 2022 56
  • Chart 3 14: Prostatic Stent Placement Procedures, U.S., 2012 - 2022 57
  • Chart 3 15: TUMT Procedures, U.S., 2012 - 2022 58
  • Chart 3 16: TUNA Procedures, U.S., 2012 - 2022 59
  • Chart 3 17: Botox® Injection Procedures, U.S., 2012 - 2022 60
  • Chart 3 18: Prostate Cancer Statistics, U.S., 2012 - 2022 62
  • Chart 3 19: Prostate Cancer Treatment Procedures by Type, U.S., 2012 - 2022 63
  • Chart 3 20: Watchful Waiting, U.S., 2012 - 2022 64
  • Chart 3 21: Prostatectomy Procedures by Approach, U.S., 2012 - 2022 67
  • Chart 3 22: Open Prostatectomy Procedures by Type, U.S., 2012 - 2022 69
  • Chart 3 23: Prostate Ablation Procedures by Modality, U.S., 2012 - 2022 71
  • Chart 3 24: Radiation Therapy Procedures by Modality, U.S., 2012 - 2022 72
  • Chart 3 25: Prostate HDR Brachytherapy Procedures, U.S., 2012 - 2022 73
  • Chart 3 26: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 - 2022 75
  • Chart 3 27: External Radiation Therapy Procedures by Modality, U.S., 2012 - 2022 77
  • Chart 3 28: Urodynamic Testing Procedures by Type, U.S., 2012 - 2022 79
  • Chart 3 29: Cystometrogram Procedures by Type, U.S., 2012 - 2022 81
  • Chart 3 30: Uroflowmetry Procedures by Type, U.S., 2012 - 2022 83
  • Chart 3 31: Nephrostomy Procedures by Type, U.S., 2012 - 2022 85
  • Chart 3 32: Nephrostomy/Nephrotomy Procedures, U.S., 2012 - 2022 86
  • Chart 3 33: Percutaneous Nephrostomy Procedures, U.S., 2012 - 2022 87
  • Chart 3 34: Erectile Dysfunction Management Procedures by Type, U.S., 2012 - 2022 90
  • Chart 3 35: Insertion of Inflatable ED Device Procedures, U.S., 2012 - 2022 91
  • Chart 3 36: Insertion of Malleable ED Device Procedures, U.S., 2012 - 2022 92
  • Chart 3 37: Removal of ED Device Procedures, U.S., 2012 - 2022 93

LIST OF FIGURES

  • Figure 1 1: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2) 3
  • Figure 1 2: Urological Devices Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2) 4
  • Figure 1 3: Companies Researched in this Report, U.S., 2015 5
  • Figure 1 4: Factors Impacting the Urological Device Market by Segment, U.S. (1 of 2) 6
  • Figure 1 5: Factors Impacting the Urological Device Market by Segment, U.S. (2 of 2) 7
  • Figure 1 6: Urological Markets Covered, U.S., 2015 (1 of 5) 8
  • Figure 1 7: Urological Markets Covered, U.S., 2015 (2 of 5) 9
  • Figure 1 8: Urological Markets Covered, U.S., 2015 (3 of 5) 10
  • Figure 1 9: Urological Markets Covered, U.S., 2015 (4 of 5) 11
  • Figure 1 10: Urological Markets Covered, U.S., 2015 (5 of 5) 12
  • Figure 1 11: Urological Procedures Covered, U.S., 2015 (1 of 2) 13
  • Figure 1 12: Urological Procedures Covered, U.S., 2015 (2 of 2) 14
  • Figure 1 13: Procedural Codes Investigated, U.S., 2015 15
  • Figure 1 14: Recent Events in the Urological Device Market, U.S., 2012 - 2015 16
  • Figure 1 15: Key Report Updates 17
  • Figure 1 16: Version History 17
  • Figure 3 1: Procedural Codes Investigated (1 of 2) 32
  • Figure 3 2: Procedural Codes Investigated (1 of 2) 33
  • Figure 3 3: Urological Procedures by Type, U.S., 2012 - 2022 (1 of 2) 34
  • Figure 3 4: Urological Procedures by Type, U.S., 2012 - 2022 (2 of 2) 35
  • Figure 3 5: Urinary Incontinence Procedures by Type, U.S., 2012 - 2022 37
  • Figure 3 6: Male Incontinence Management Procedures by Type, U.S., 2012 - 2022 (1 of 2) 38
  • Figure 3 7: Male Incontinence Management Procedures by Type, U.S., 2012 - 2022 (2 of 2) 39
  • Figure 3 8: Female Incontinence Management Procedures by Type, U.S., 2012 - 2022 (1 of 2) 41
  • Figure 3 9: Female Incontinence Management Procedures by Type, U.S., 2012 - 2022 (2 of 2) 42
  • Figure 3 10: Stone Management Procedures by Type, U.S., 2012 - 2022 44
  • Figure 3 11: ESWL Procedures, U.S., 2012 - 2022 46
  • Figure 3 12: Transurethral Procedures by Type, U.S., 2012 - 2022 47
  • Figure 3 13: Ureteral Stent Placement Procedures, U.S., 2012 - 2022 49
  • Figure 3 14: PCNL Procedures, U.S., 2012 - 2022 50
  • Figure 3 15: BPH Patient Statistics, U.S., 2012 - 2022 51
  • Figure 3 16: BPH Procedures by Type, U.S., 2012 - 2022 (1 of 2) 53
  • Figure 3 17: BPH Procedures by Type, U.S., 2012 - 2022 (2 of 2) 53
  • Figure 3 18: TURP Procedures, U.S., 2012 - 2022 55
  • Figure 3 19: Laser BPH Procedures, U.S., 2012 - 2022 56
  • Figure 3 20: Prostatic Stent Placement Procedures, U.S., 2012 - 2022 57
  • Figure 3 21: TUMT Procedures, U.S., 2012 - 2022 58
  • Figure 3 22: TUNA Procedures, U.S., 2012 - 2022 59
  • Figure 3 23: Botox® Injection Procedures, U.S., 2012 - 2022 60
  • Figure 3 24: Prostate Cancer Statistics, U.S., 2012 - 2022 61
  • Figure 3 25: Prostate Cancer Treatment Procedures by Type, U.S., 2012 - 2022 63
  • Figure 3 26: Watchful Waiting, U.S., 2012 - 2022 64
  • Figure 3 27: Prostatectomy Procedures by Approach, U.S., 2012 - 2022 (1 of 2) 66
  • Figure 3 28: Prostatectomy Procedures by Approach, U.S., 2012 - 2022 (2 of 2) 66
  • Figure 3 29: Open Prostatectomy Procedures by Type, U.S., 2012 - 2022 (1 of 2) 68
  • Figure 3 30: Open Prostatectomy Procedures by Type, U.S., 2012 - 2022 (2 of 2) 68
  • Figure 3 31: Prostate Ablation Procedures by Modality, U.S., 2012 - 2022 (1 of 2) 70
  • Figure 3 32: Prostate Ablation Procedures by Modality, U.S., 2012 - 2022 (2 of 2) 71
  • Figure 3 33: Radiation Therapy Procedures by Modality, U.S., 2012 - 2022 72
  • Figure 3 34: Prostate HDR Brachytherapy Procedures, U.S., 2012 - 2022 73
  • Figure 3 35: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 - 2022 (1 of 2) 74
  • Figure 3 36: Prostate LDR Brachytherapy Procedures by Seed Type, U.S., 2012 - 2022 (2 of 2) 75
  • Figure 3 37: External Radiation Therapy Procedures by Modality, U.S., 2012 - 2022 76
  • Figure 3 38: Urodynamic Testing Procedures by Type, U.S., 2012 - 2022 78
  • Figure 3 39: Cystometrogram Procedures by Type, U.S., 2012 - 2022 80
  • Figure 3 40: Uroflowmetry Procedures by Type, U.S., 2012 - 2022 82
  • Figure 3 41: Nephrostomy Procedures by Type, U.S., 2012 - 2022 84
  • Figure 3 42: Nephrostomy/Nephrotomy Procedures, U.S., 2012 - 2022 86
  • Figure 3 43: Percutaneous Nephrostomy Procedures, U.S., 2012 - 2022 87
  • Figure 3 44: Erectile Dysfunction Management Procedures by Type, U.S., 2012 - 2022 89
  • Figure 3 45: Insertion of Inflatable ED Device Procedures, U.S., 2012 - 2022 91
  • Figure 3 46: Insertion of Malleable ED Device Procedures, U.S., 2012 - 2022 92
  • Figure 3 47: Removal of ED Device Procedures, U.S., 2012 - 2022 93
Back to Top